Dr. Mihwa Cindy Pak, MD

Dr. Pak practices at West Los Angeles Medical Center in Los Angeles, California, part of Kaiser Permanente.

Dr. Pak's NPI, 1053590315, was assigned on November 2, 2007. Dr. Pak graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 2001. Dr. Pak holds California license A81890.

Dr. Pak's primary practice is West Los Angeles Medical Center, at 6041 Cadillac Ave, Los Angeles, CA 90034 in Los Angeles County. The practice phone is (213) 857-2201.

Dr. Pak's primary practice is West Los Angeles Medical Center in Los Angeles, California, part of Kaiser Permanente. The medical group on file is Southern California Permanente Medical Group. Dmand AI also links Dr. Pak to 1 more dialysis center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pak practices, 2 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Pak's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Pak is board certified in critical care medicine by the American Board of Internal Medicine. Dr. Pak is licensed in California.

Dmand AI lists chronic diabetes, chronic hypertension, chronic lung disease, chronic respiratory failure, cirrhosis of the liver and obesity among the conditions Dr. Pak treats.

CMS data shows 51 Medicare services from Dr. Pak across 1 procedure code in 2024, for 32 Medicare patients. Medicare paid $8,813 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 32 Medicare patients who saw Dr. Pak in 2024. The largest group is under 65, with 12 patients. 75% of them have high blood pressure, and 72% have heart failure. Their average risk score is 4.40, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Pak's median patient age at 66, with 59% women.

In 2024, Dr. Pak wrote 1,060 Medicare Part D claims for 202 patients. 44% of them were for generic drugs. CMS names the drug for 883 of them, across 14 drugs with 11 or more claims each, at $270,128 in total drug cost. In 2023, CMS named 902 claims across 15 drugs.

Dr. Pak accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Pak as offering telehealth.

CMS Open Payments shows 4 general payments to Dr. Pak from 4 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 100% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $143.

Dmand AI lists 1 award for Dr. Pak, most recently CMS Stage 1 2012 in 2011.

Dr. Pak graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 2001.

Dr. Pak is in network with 2 carriers, including CMS Medicare and Kaiser Permanente. Medicare plans come from the most carriers, 1. Check the plan with the practice before a visit.